IAS Meeting To Highlight Collaboration to Improve Outcomes of Patients with Immune-mediated Diseases

02/21/2018
boston

The 2018 Interdisciplinary Autoimmune Summit (IAS) will be held at the Westin Waterfront in Boston, MA from April 27 through April 29. The meeting brings together dermatologists, rheumatologists, gastroenterologists, immunologists, internists, and other health care professionals to discuss and collaborate on optimal treatment strategies for patients with immune-mediated inflammatory diseases (IMIDs). Complex cases will be discussed on psoriasis, psoriatic arthritis, rheumatoid arthritis, spondyloarthropathies, Crohn disease, and ulcerative colitis.

“IAS provides an opportunity to create cross-talk between the medical subspecialties that focus on immune-mediated inflammatory diseases. While the epidemiology and immune-inflammatory pathways overlap, we can learn from our mutual successes [and failures] as to how to optimize management of these chronic diseases,” said IAS Senior Advisor Stephen B. Hanauer, MD, Clifford Joseph Barborka Professor of Medicine at Northwestern Feinberg School of Medicine and Medical Director of the Digestive Health Center.

senior advisors

 

 

 

 

 

 


Advisors for the 5th annual meeting (from left to right) include Leonard H. Calabrese, DO; Joel M. Gelfand, MD, MSCE; and Dr Hanauer.

cochairs

 

 

 

 

 

 


New 2018 IAS Co-Chairs (from left to right) are Adam S. Cheifetz, MD; Joseph F. Merola, MD, MMSc, FAAD, FACR; Mital Patel, MD. 

Program Highlights

This year’s summit will include more than 28 sessions and 3 tailored educational tracks where attendees can earn up to 15.75 CME/CNE/CPE credits. These sessions will:

  • describe the relationships between the pathophysiology of IMIDs and the mechanism-of-action of new and existing treatments
  • outline the roles of current and emerging immunosuppressive, anti-inflammatory, and disease-modifying therapies for IMIDs in treatment paradigms
  • develop collaborative care guidance to improve the management of patients with multiple manifestations of IMIDs

Each presentation is followed by a question and answer session with the faculty.

The Keynote Presentation, “Patient Perspective: Living Life with Multiple Immune-Mediated Inflammatory Diseases” will be given by Lilly Stairs, head of patient advocacy at Clara Health, and also a board member of the American Autoimmune Related Diseases Association. Ms. Stairs is responsible for conceiving and executing patient engagement strategy and ensuring the patient voice remains firmly at the center of Clara Health.

Dermatology Specific Sessions

Must-see sessions for dermatologists include:

  • Updates in Neutrophilic Dermatoses; Friday April 27; 1:35 pm to 2:20 pm
  • New Advances in the Treatment of Moderate to Severe Psoriasis; Dr Gelfand; April 27; 2:20 pm to 3:05 pm
  • Applying Advances in Psoriatic Diseases to Individualized Treatment to Optimize Outcomes; April 28; 8:35 am to 9:35 am
  • New Advances of the Impact on Anti-Inflammatory Treatment on Cardiovascular Risk; Dr Gelfand; April 28; 9:35 am to 10:20 am
  • Novel Insights in Atopic Dermatitis; April 28; 1:10 pm to 1:55 pm
  • Overlap of Pyoderma Gangrenosum; Dr Patel; April 28; 1:55 pm to 2:40 pm
  • Clinical Assessment of PsO/PsA: Patient Demonstration; April 28; 9:35 am to 10:35 am
  • Predicting and Preventing Serious Infections with Biologic Therapies; Kevin Winthrop, MD, MPH; April 29; 3:00 pm to 3:45 pm

Hot Topics

In addition, the meeting will include presentations on “hot topics” from 11:25 am to 12:10 pm on Friday, April 27. The session will focus on the latest research in IMID and its application to clinical practice, as well as explore new and emerging agents and other hot topics on autoimmune diseases.

For more information about the meeting, please visit http://www.iasmeeting.com/.

Photos courtesy of IAS